Troels Koch

This inventor holds 25 USPTO granted patents and 20 published patent applications, plus 3 CIPO patents and 17 EPO patents, primarily in Nucleic Acid Chemistry. Top assignees: Roche Innovation Center Copenhagen A/s, Santaris Pharma A/s, Dako A/s. Active years: 2000-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Troels Koch. Retrieved from https://idiyas.com/inventor/troels-koch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 20)

% Patents Active = 76.0

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 17 (Patent Applications = 17)

Average Co-Inventor Count = 4.7

ph-index = 13

Forward Citations = 844(Granted Patents)

Location History:

Kobenhaven, DK (2000)
Kopenhagen, DK (2000 - 2001)
Kobenhaven S, DK (2001)
Kopenhagen S., DK (2002)
Kobenhaven S., DK (2003)
København S, DK (2009 - 2011)
København, DK (2013)
Copenhagen, DK (2000 - 2018)
Horsholm, DK (2020)
Hørsholm, DK (2023)

Company Filing History:

9 out of 46

Roche Innovation Center Copenhagen A/s

Roche Diagnostics Gmbh

patents

5. 1 out of 2,193

Georgia Tech Research Corporation

7. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2023

Loading Chart...

Areas of Expertise:

Thiophosphoramidites

Chiral Library Screen

Antisense Design

Short Interfering RNA

Locked Nucleic Acid

Oligonucleotides

Peptide Nucleic Acids

Signal Amplification

Photochemical Immobilization

Nucleic Acid Preparation

Monomeric Building Blocks

Geometric Structures

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11597926 - Thiophosphoramidites (2023-03-07),

2. 10815481 - Chiral library screen (2020-10-27),

3. 9994850 - Antisense design (2018-06-12),

4. 9951333 - Antisense design (2018-04-24),

5. 9890383 - Antisense design (2018-02-13),

6. 9738894 - Short interfering RNA (siRNA) analogues (2017-08-22),

7. 9708614 - Antisense design (2017-07-18),

8. 9428534 - Antisense design (2016-08-30),

9. 9297010 - Short interfering RNA (siRNA) analogues (2016-03-29),

10. 9045518 - Amino-LNA, thio-LNA and alpha-L-oxy-LN (2015-06-02),

11. 8653252 - Short interfering RNA (siRNA) analogues (2014-02-18),

12. 8492390 - Synthesis of locked nucleic acid derivatives (2013-07-23),

13. 8084458 - Synthesis of locked nucleic acid derivatives (2011-12-27),

14. 7687617 - Oligonucleotides with alternating segments of locked and non-locked nucleotides (2010-03-30),

15. 7569575 - Synthesis of locked nucleic acid derivatives (2009-08-04),

Title: Unveiling the Remarkable Contributions of Inventor Troels Koch

Introduction: Troels Koch, a prolific inventor based in Copenhagen, DK, has left an indelible mark in the field of innovations with his extraordinary work. With an impressive tally of 25 patents under his belt, Koch has significantly contributed to the realm of science and technology.

Latest Patents: Among his recent inventions, Koch introduced groundbreaking patents such as "Thiophosphoramidites," revolutionizing the manufacturing process of oligonucleotides. Moreover, his invention of the "Chiral library screen" method has paved the way for identifying phosphorothioate oligonucleotide variants with reduced toxicity, marking a significant advancement in the field.

Career Highlights: Koch's noteworthy career includes tenure at renowned companies such as Santaris Pharma A/S and Roche Innovation Center Copenhagen A/S. His expertise and dedication have been instrumental in driving innovation and shaping the landscape of scientific advancements.

Collaborations: Throughout his career, Koch has collaborated closely with esteemed professionals, including his esteemed coworkers Henrik Frydenlund Hansen and Christoph Rosenbohm. Together, they have spearheaded groundbreaking projects and propelled the boundaries of scientific research.

Conclusion: In conclusion, Troels Koch's inventive genius and unwavering commitment to excellence have solidified his position as a trailblazer in the world of innovations. His remarkable contributions continue to inspire and redefine the possibilities within the realms of science and technology.

Profile summary based on public USPTO records.